Results 151 to 160 of about 4,187 (189)

Development of a novel ¹⁸F-labeled reversible-binding radioligand for imaging monoacylglycerol lipase with positron emission tomography. [PDF]

Acta Pharm Sin B
Rong J, Zhao C, Chaudhary AF, Ware T, Van RS, Li Y, Calderon Leon ER, Dang V, Chen J, Xiao Z, Zhou X, Zhang W, Bi C, Zhang K, Patel JS, Shao Y, Ran C, Collin L, Haider A, Cravatt BF, Liang SH.   +20 more
europepmc   +1 more source

Cannabinoids in immune system-related diseases: From bench to clinic. [PDF]

Chin Med J (Engl)
Zhang W, Chen B, Cao Y, Lei W, Zhao H, Yang Y, Tang J.   +6 more
europepmc   +1 more source

Genome-wide characterization of monoacylglycerol lipase (MAGL) gene family in soybean and functional analysis of GmMAGLs in storage lipid metabolism and drought resistance. [PDF]

BMC Genomics
Jing H, Sun Y, Wang B, Ma J, Wan K, Li Z, Zhou Y, Li R, Zhang H, Xue J.   +9 more
europepmc   +1 more source

Endocannabinoid responses to relief of obstruction in acute injured kidney: a prospective observational study. [PDF]

Ther Adv Urol
Rothner A, Fishberg SE, Hinden L, Atias E, Nemirovski A, Gofrit ON, Tam J, Hidas G.   +7 more
europepmc   +1 more source

Neka obilježja magle u Središnjoj Hrvatskoj

U ovom se radu istražuje utjecaj klimatskih modifikatora na području promatranih postaja (blizina rijeke, reljefa, nadmorske visine, zemljišnog pokrova i drugo) na učestalost pojave i geografsku raspodjelu magle u Središnjoj Hrvatskoj. Uspoređeni su podaci o godišnjem hodu broja dana s maglom te promjene u godišnjem broju dana s maglom u ...
openaire   +1 more source

Flavonoid carbamate hybrids: design, synthesis, and evaluation as multi-target enzyme inhibitors for Alzheimer's disease. [PDF]

RSC Adv
Tran TH, Doan DN, Cao TC, Tran TS, Tran TD.   +4 more
europepmc   +1 more source

Advances in neuropsychiatry: From objective diagnostics to mechanism-based therapeutics. [PDF]

Neurotherapeutics
Pieper AA, Lee FS.
europepmc   +1 more source

Deep learning-enhanced QSAR modeling for predicting developmental neurotoxicity based on molecular initiating events from adverse outcome pathways. [PDF]

Mol Divers
de Sousa Pereira E, Costa VAF, de Almeida Santos ES, Neves BJ.   +3 more
europepmc   +1 more source